Arch Therapeutics Management
Management criteria checks 2/4
Arch Therapeutics' CEO is Terrence Norchi, appointed in Jan 2006, has a tenure of 18.33 years. total yearly compensation is $491.00K, comprised of 91.8% salary and 8.2% bonuses, including company stock and options. directly owns 1.69% of the company’s shares, worth $88.53K. The average tenure of the management team and the board of directors is 3 years and 1.3 years respectively.
Key information
Terrence Norchi
Chief executive officer
US$491.0k
Total compensation
| CEO salary percentage | 91.8% |
| CEO tenure | 18.3yrs |
| CEO ownership | 1.7% |
| Management average tenure | 3yrs |
| Board average tenure | 1.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$8m |
| Sep 30 2023 | US$491k | US$451k | -US$7m |
| Jun 30 2023 | n/a | n/a | -US$6m |
| Mar 31 2023 | n/a | n/a | -US$6m |
| Dec 31 2022 | n/a | n/a | -US$6m |
| Sep 30 2022 | US$451k | US$451k | -US$5m |
| Jun 30 2022 | n/a | n/a | -US$5m |
| Mar 31 2022 | n/a | n/a | -US$6m |
| Dec 31 2021 | n/a | n/a | -US$7m |
| Sep 30 2021 | US$635k | US$451k | -US$6m |
| Jun 30 2021 | n/a | n/a | -US$6m |
| Mar 31 2021 | n/a | n/a | -US$5m |
| Dec 31 2020 | n/a | n/a | -US$4m |
| Sep 30 2020 | US$698k | US$438k | -US$5m |
| Jun 30 2020 | n/a | n/a | -US$4m |
| Mar 31 2020 | n/a | n/a | -US$5m |
| Dec 31 2019 | n/a | n/a | -US$4m |
| Sep 30 2019 | US$429k | US$429k | -US$5m |
| Jun 30 2019 | n/a | n/a | -US$5m |
| Mar 31 2019 | n/a | n/a | -US$6m |
| Dec 31 2018 | n/a | n/a | -US$8m |
| Sep 30 2018 | US$829k | US$425k | -US$5m |
| Jun 30 2018 | n/a | n/a | -US$6m |
| Mar 31 2018 | n/a | n/a | -US$6m |
| Dec 31 2017 | n/a | n/a | -US$6m |
| Sep 30 2017 | US$1m | US$350k | -US$8m |
Compensation vs Market: Terrence's total compensation ($USD491.00K) is about average for companies of similar size in the US market ($USD667.63K).
Compensation vs Earnings: Terrence's compensation has increased whilst the company is unprofitable.
CEO
Terrence Norchi (58 yo)
18.3yrs
Tenure
US$491,000
Compensation
Dr. Terrence W. Norchi, M.D., serves as Chairman of the Board at Arch Therapeutics, Inc. since July 19, 2018. He is the Co-Founder of Arch Therapeutics, Inc. and has been its Chief Executive Officer and Pr...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 18.3yrs | US$491.00k | 1.69% $ 88.5k | |
| CFO & Treasurer | 3yrs | US$354.16k | 0.24% $ 12.8k | |
| Co-Founder & Scientific Advisor | no data | no data | no data | |
| Vice President of Sales | less than a year | no data | no data |
3.0yrs
Average Tenure
Experienced Management: ARTH's management team is considered experienced (3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 11.1yrs | US$491.00k | 1.69% $ 88.5k | |
| Independent Director | 2.4yrs | US$18.35k | 0% $ 0 | |
| Independent Director | 5.8yrs | US$20.60k | 0% $ 0 | |
| Member of Medical Advisory Board | 1.3yrs | no data | no data | |
| Member of Medical Advisory Board | 1.3yrs | no data | no data | |
| Independent Director | 2.7yrs | US$8.10k | 0% $ 0 | |
| Member of Medical Advisory Board | 1.3yrs | no data | no data | |
| Member of Medical Advisory Board | 1.3yrs | no data | no data | |
| Member of Medical Advisory Board | 1.3yrs | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data |
1.3yrs
Average Tenure
58yo
Average Age
Experienced Board: ARTH's board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.